On December 22, 2025, the FDA approved the first pill form of semaglutide to help with weight loss. This makes it the first GLP-1 medication for obesity that comes as a pill, instead of an injection.
The medication uses the same active ingredient as Wegovy and Ozempic. The pill is expected to be available in early 2026.
This approval puts Novo Nordisk ahead of other companies that are still working on weight-loss pills. The starting price is expected to be about $149 per month.
Can people with type 1 and type 2 diabetes get ahold of this medication? Time will tell.
Learn more about GLP-1 medications in diabetes here:
- How Do Zepbound & Mounjaro Work?
- How Does Ozempic Work?
- 1 Year on Ozempic
- Getting Ozempic with T1D
- My First Month on Ozempic
- 5 Other Hormones
- Before You Start Taking GLP-1
- GLP-1 Side-Effects
- Yes, I Microdose Ozempic as a Person with T1D!
- 5 Mistakes GLP-1 Newbies Don’t Realize They’re Making
Ginger Vieira has lived with type 1 diabetes since 1999 along with a few other chronic illnesses! She is the Cofounder of the Diabetes Nerd Network and the Diabetes Nerd Marketing agency. Ginger has authored hundreds of articles and several books, including Exercise with Type 1 Diabetes, Pregnancy with Type 1 Diabetes, Dealing with Diabetes Burnout, and Stop Overeating During Lows. Over her 20-year career (so far) in diabetes, she’s produced hundreds of articles and videos about life with diabetes. Her background includes a Bachelor of Science in professional writing and certifications in coaching, personal training, powerlifting, and Ashtanga yoga.